Skip to main content
. 2006 Sep 27;4:17. doi: 10.1186/1477-9560-4-17

Table 2.

Incidence of venous thromboembolism and adverse events among medical inpatients receiving enoxaparin versus UFH prophylaxis

Prophylaxis Received [N(%)]

Outcome Enoxaparin (N = 479) UFH (N = 2,837) RR (95% CI)
DVT 8 (1.7) 163 (5.8) 0.29 (0.14, 0.59)
PE 0 (0.0) 32 (1.1) 0
VTE (DVT and/or PE) 8 (1.7) 180 (6.3) 0.26 (0.13,0.53)
Adverse Events:
 HIT 0 (0.0) 0 (0.0) --
 Major Bleed 12 (2.5) 72 (2.5) 0.99 (0.54,1.80)
 Death 25 (5.2) 142 (5.0) 1.04 (0.69, 1.58)

DVT = deep-vein thrombosis; PE = pulmonary embolism; VTE = venous thromboembolism; HIT = heparin-induced thrombocytopenia